Commercial launch follows successful pilot, with customers reporting improved clinical decision-making and greater confidence ...
INOVIO delivers a new nonsurgical treatment option with a broad indication for adults living with RRP, a rare and ...
ATR 1072 impacted key characteristics of PRKAG2 syndrome, including accumulation of cardiac glycogen and cardiac hypertrophy ...
Guggenheim 3rd Annual Healthcare Innovation Conference. Erik Lundgren, Chief Executive Officer, and Jason Tardio, President ...
Throughout November, LUNGevity will mobilize communities nationwide to support research, expand awareness of early detection, ...
Poster presentations feature preclinical in vitro and in vivo data of potentially first-in-class oral small molecule GIPR ...
Bavarian Nordic A/S (OMX: BAVA) announces that the share buy-back program, which was announced and initiated on September 1, ...
Vicore Pharma is a clinical-stage biopharmaceutical company unlocking the potential of a new class of drugs with ...
Björn Tackenberg, M.D. Ph.D. FEAN FAAN, Professor of Neurology, will lead Oculis’ global integrated scientific strategy ...
A fresh FDA review for Biohaven’s embattled ataxia drug lifted the biotech's shares, while a late-stage lung cancer miss ...
Update on discussions with financial partners. Villepinte, November 2, 2026, 8.30 A.m.: Guerbet (FR0000032526 GBT), a global ...
New fixed, single-room configuration is designed to make DeepOCT+NIRS Imaging and X1-FFR physiology readily available for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results